Ohara Pharmaceutical
Japan - ShigaPharmaceutical
Focus: Ohara Pharmaceutical is a Japan-based small molecule and generic drug manufacturer focused on gastroenterology, oncology, and infectious diseases. The company operates as a regional player in the pharmaceutical market with a pipeline concentrated in early-stage development.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About Ohara Pharmaceutical
AI assessmentNot HiringNo open roles listed right now. Follow Ohara Pharmaceutical to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
OP-724
Liver CirrhosisClinical Trials (1)
NCT04688034Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV with Hemophilia.
Phase 1Help build intelligence for Ohara Pharmaceutical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.